BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 17962197)

  • 1. Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.
    Page RM; Baumann K; Tomioka M; Pérez-Revuelta BI; Fukumori A; Jacobsen H; Flohr A; Luebbers T; Ozmen L; Steiner H; Haass C
    J Biol Chem; 2008 Jan; 283(2):677-83. PubMed ID: 17962197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase.
    Czirr E; Cottrell BA; Leuchtenberger S; Kukar T; Ladd TB; Esselmann H; Paul S; Schubenel R; Torpey JW; Pietrzik CU; Golde TE; Wiltfang J; Baumann K; Koo EH; Weggen S
    J Biol Chem; 2008 Jun; 283(25):17049-54. PubMed ID: 18426795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.
    Czirr E; Leuchtenberger S; Dorner-Ciossek C; Schneider A; Jucker M; Koo EH; Pietrzik CU; Baumann K; Weggen S
    J Biol Chem; 2007 Aug; 282(34):24504-13. PubMed ID: 17573346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis.
    Islam S; Sun Y; Gao Y; Nakamura T; Noorani AA; Li T; Wong PC; Kimura N; Matsubara E; Kasuga K; Ikeuchi T; Tomita T; Zou K; Michikawa M
    J Neurosci; 2022 Feb; 42(8):1574-1586. PubMed ID: 34987110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic characteristics of I213T mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein C-terminal fragment beta.
    Shimojo M; Sahara N; Mizoroki T; Funamoto S; Morishima-Kawashima M; Kudo T; Takeda M; Ihara Y; Ichinose H; Takashima A
    J Biol Chem; 2008 Jun; 283(24):16488-96. PubMed ID: 18430735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.
    Kim M; Bezprozvanny I
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-amino acid spacing of presenilin endoproteolysis suggests a general stepwise cleavage of gamma-secretase-mediated intramembrane proteolysis.
    Fukumori A; Fluhrer R; Steiner H; Haass C
    J Neurosci; 2010 Jun; 30(23):7853-62. PubMed ID: 20534834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer's Disease.
    Kim M; Bezprozvanny I
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.
    Quintero-Monzon O; Martin MM; Fernandez MA; Cappello CA; Krzysiak AJ; Osenkowski P; Wolfe MS
    Biochemistry; 2011 Oct; 50(42):9023-35. PubMed ID: 21919498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of gamma-secretase inhibitor potency determinants on presenilin.
    Zhao B; Yu M; Neitzel M; Marugg J; Jagodzinski J; Lee M; Hu K; Schenk D; Yednock T; Basi G
    J Biol Chem; 2008 Feb; 283(5):2927-38. PubMed ID: 18032377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified γ-secretase complexes.
    Cacquevel M; Aeschbach L; Houacine J; Fraering PC
    PLoS One; 2012; 7(4):e35133. PubMed ID: 22529981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity.
    Heilig EA; Xia W; Shen J; Kelleher RJ
    J Biol Chem; 2010 Jul; 285(29):22350-9. PubMed ID: 20460383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
    Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
    Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ43-producing PS1 FAD mutants cause altered substrate interactions and respond to γ-secretase modulation.
    Trambauer J; Rodríguez Sarmiento RM; Fukumori A; Feederle R; Baumann K; Steiner H
    EMBO Rep; 2020 Jan; 21(1):e47996. PubMed ID: 31762188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that enzyme processivity mediates differential Aβ production by PS1 and PS2.
    Pintchovski SA; Schenk DB; Basi GS
    Curr Alzheimer Res; 2013 Jan; 10(1):4-10. PubMed ID: 22950863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Abeta42 responses to low potency gamma-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds.
    Kretner B; Fukumori A; Gutsmiedl A; Page RM; Luebbers T; Galley G; Baumann K; Haass C; Steiner H
    J Biol Chem; 2011 Apr; 286(17):15240-51. PubMed ID: 21357415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor Mutations for Presenilin 1 Familial Alzheimer Disease Mutants Modulate γ-Secretase Activities.
    Futai E; Osawa S; Cai T; Fujisawa T; Ishiura S; Tomita T
    J Biol Chem; 2016 Jan; 291(1):435-46. PubMed ID: 26559975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.